Moreover, in both primary breast cancer and uveal melanoma, higher PRAME expression levels correlate with an increased rate of distant metastases [6, 8] and may promote epithelial-to-mesenchymal transition during tumor invasion [11]. The gene discussed is PRAME; the disease is breast carcinoma.